Alice Melão, MSc,  —

Articles by Alice Melão

AIT’s Nitric Oxide Therapy Helps CF Patients with an Infection Breathe and Function Better

AIT Therapeutics’ inhaled nitric oxide formulation improved the breathing and physical functioning of cystic fibrosis patients with a lung infection, a Phase 2 clinical trial shows. The preliminary results applied to the formulation’s use against nontuberculous mycobacteria, which are collectively known as the mycobacterium abscessus complex. AIT said the NO-NTM…

Interim Data from Clinical Trial Support MS1819 as Potential Therapy for EPI in CF Patients

Interim data from an ongoing Phase 2a clinical trial indicate that the investigational therapy MS1819-SD may provide therapeutic benefits for patients with cystic fibrosis (CF) who have exocrine pancreatic insufficiency (EPI), a digestive disorder. The trial (ACTRN12616000962437) is being conducted in patients with chronic pancreatitis (CP) who have EPI, but the drug is being…

Your CF Community

Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.